Instadose Pharma Corp. (INSD)

USD 0.0

(0.0%)

Operating Expenses Summary of Instadose Pharma Corp.

Instadose Pharma Corp.'s latest annual operating expenses in 2023 was - USD , down -100.0% from previous year.
Instadose Pharma Corp.'s latest quarterly operating expenses in 2024 Q1 was - USD , down 0.0% from previous quarter.
Instadose Pharma Corp. reported a annual operating expenses of 588.71 Thousand USD in annual operating expenses 2022, up 1667.22% from previous year.
Instadose Pharma Corp. reported a annual operating expenses of 33.31 Thousand USD in annual operating expenses 2021, up 7.71% from previous year.
Instadose Pharma Corp. reported a quarterly operating expenses of - USD for 2023 Q3, down 0.0% from previous quarter.
Instadose Pharma Corp. reported a quarterly operating expenses of - USD for 2023 FY, down -100.0% from previous quarter.

Annual Operating Expenses Chart of Instadose Pharma Corp. (2023 - 2017)

Historical Annual Operating Expenses of Instadose Pharma Corp. (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	- USD	-100.0%
2022	588.71 Thousand USD	1667.22%
2021	33.31 Thousand USD	7.71%
2020	30.92 Thousand USD	-6.36%
2019	33.02 Thousand USD	-19.67%
2018	41.11 Thousand USD	2018.08%
2017	1941.00 USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	- USD	0.0%
2023 Q3	- USD	0.0%
2023 FY	- USD	-100.0%
2023 Q4	- USD	0.0%
2023 Q1	- USD	0.0%
2023 Q2	- USD	0.0%
2022 FY	588.71 Thousand USD	1667.22%
2022 Q3	1.12 Million USD	152.09%
2022 Q2	446.25 Thousand USD	569.77%
2022 Q1	66.62 Thousand USD	15.0%
2021 Q3	15.5 Thousand USD	49.7%
2021 Q1	5355.89 USD	-18.91%
2021 Q4	57.93 Thousand USD	273.64%
2021 Q2	10.35 Thousand USD	93.39%
2021 FY	33.31 Thousand USD	7.71%
2020 FY	30.92 Thousand USD	-6.36%
2020 Q4	6605.23 USD	-44.25%
2020 Q3	11.84 Thousand USD	105.05%
2020 Q2	5778.15 USD	-13.38%
2020 Q1	6670.52 USD	6.46%
2019 Q3	12.08 Thousand USD	133.64%
2019 Q2	5173.71 USD	2.8%
2019 Q1	5032.66 USD	-34.72%
2019 FY	33.02 Thousand USD	-19.67%
2019 Q4	6265.74 USD	-48.17%
2018 Q3	14.93 Thousand USD	-30.26%
2018 Q1	4897.76 USD	33.66%
2018 Q4	7709.74 USD	-48.37%
2018 Q2	21.41 Thousand USD	337.22%
2018 FY	41.11 Thousand USD	2018.08%
2017 Q2	2607.81 USD	0.0%
2017 Q3	11.87 Thousand USD	355.48%
2017 FY	1941.00 USD	0.0%
2017 Q4	3664.33 USD	-69.15%

Peer Operating Expenses Comparison of Instadose Pharma Corp.

Name	Operating Expenses	Operating Expenses Difference
BioQuest Corp.	89.76 USD	100.0%
GSRX Industries Inc.	- USD	NaN%
High Sierra Technologies, Inc.	238.36 Thousand USD	100.0%